151 related articles for article (PubMed ID: 1711382)
1. The effects of typical and atypical neuroleptics on mitogen-induced T lymphocyte responsiveness.
Rapaport MH; McAllister CG; Kirch DG; Pickar D
Biol Psychiatry; 1991 Apr; 29(7):715-7. PubMed ID: 1711382
[No Abstract] [Full Text] [Related]
2. Short and long-term immunosuppressive effects of clozapine and haloperidol.
Leykin I; Mayer R; Shinitzky M
Immunopharmacology; 1997 Aug; 37(1):75-86. PubMed ID: 9285246
[TBL] [Abstract][Full Text] [Related]
3. [Schizophrenia and immunity].
Galinowski A; Levy-Soussan P; Lôo H
Ann Med Psychol (Paris); 1992; 150(2-3):138-42. PubMed ID: 1364190
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of clozapine partial responders with conventional antipsychotics.
Rajarethinam R; Gilani S; Tancer M; DeQuardo J
Schizophr Res; 2003 Mar; 60(1):97-8. PubMed ID: 12505145
[No Abstract] [Full Text] [Related]
5. Is dopamine related to immunologic changes in schizophrenic patients?
Kerepcić I; Bamburac J; Jurin M
Ann N Y Acad Sci; 1987; 496():737-9. PubMed ID: 2886098
[No Abstract] [Full Text] [Related]
6. Reduced lymphocyte response to PHA and OKT3 in drug-free and neuroleptic-treated chronic schizophrenics.
Monteleone P; Valente B; Maj M; Kemali D
Biol Psychiatry; 1991 Jul; 30(2):201-4. PubMed ID: 1680471
[No Abstract] [Full Text] [Related]
7. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
[No Abstract] [Full Text] [Related]
8. Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation.
Volavka J; Nolan KA; Kline L; Czobor P; Citrome L; Sheitman B; Lindenmayer JP; McEvoy J; Lieberman JA
Schizophr Res; 2005 Jul; 76(1):127-9. PubMed ID: 15927808
[No Abstract] [Full Text] [Related]
9. Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine.
Pickar D; Owen RR; Litman RE; Konicki E; Gutierrez R; Rapaport MH
Arch Gen Psychiatry; 1992 May; 49(5):345-53. PubMed ID: 1375019
[TBL] [Abstract][Full Text] [Related]
10. Effects of short-term administration of antipsychotic drugs on lymphocyte subsets in schizophrenic patients.
McAllister CG; Rapaport MH; Pickar D; Paul SM
Arch Gen Psychiatry; 1989 Oct; 46(10):956-7. PubMed ID: 2572208
[No Abstract] [Full Text] [Related]
11. Schizophrenia.
Lawrie S; McIntosh A; Nadeem Z
Clin Evid; 2005 Dec; (14):1306-30. PubMed ID: 16620456
[No Abstract] [Full Text] [Related]
12. Treatment of clozapine-associated tardive dyskinesia.
Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744
[No Abstract] [Full Text] [Related]
13. Low serum neuroleptic levels predict relapse in schizophrenic patients.
Brown WA; Laughren T; Chisholm E; Williams BW
Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172
[TBL] [Abstract][Full Text] [Related]
14. Specific indications for different classes of phenothiazines.
Hollister LE; Overall JE; Kimbell I; Pokorny A
Arch Gen Psychiatry; 1974 Jan; 30(1):94-9. PubMed ID: 4148660
[No Abstract] [Full Text] [Related]
15. Autonomic effects of clozapine in schizophrenia: comparison with placebo and fluphenazine.
Zahn TP; Pickar D
Biol Psychiatry; 1993 Jul 1-15; 34(1-2):3-12. PubMed ID: 8104043
[TBL] [Abstract][Full Text] [Related]
16. [Atypical neuroleptics in the treatment of aggression and hostility in schizophrenic patients].
Briken P; Nika E; Krausz M; Naber D
Fortschr Neurol Psychiatr; 2002 Mar; 70(3):139-44. PubMed ID: 11880946
[TBL] [Abstract][Full Text] [Related]
17. Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics.
Melkersson K; Lewitt M; Hall K
Neuro Endocrinol Lett; 2015; 36(5):465-80. PubMed ID: 26707048
[TBL] [Abstract][Full Text] [Related]
18. [Changes in the functional activity of T-lymphocytes after administration of stelazine].
Androsova LV; Sekirina TP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(8):87-9. PubMed ID: 1684460
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic effects on serine and glycine metabolism.
Baruah S; Waziri R; Sherman A
Biol Psychiatry; 1993 Oct; 34(8):544-50. PubMed ID: 7903868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
